Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SGEN | Common Stock | Options Exercise | $90.3K | +4.5K | +9.73% | $20.06* | 50.8K | Jan 14, 2022 | Direct | F1 |
transaction | SGEN | Common Stock | Sale | -$609K | -4.5K | -8.87% | $135.24 | 46.3K | Jan 14, 2022 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -4.5K | -25.71% | $0.00 | 13K | Jan 14, 2022 | Common Stock | 4.5K | $20.06 | Direct | F3 |
Id | Content |
---|---|
F1 | Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. |
F2 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. |
F3 | Options were fully vested on 5/17/13. |